Amprion
PrivateLast Round
Series B
Oct 9, 2024
Total Funding Raised
$16.66M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Amprion is a biotechnology company that develops diagnostic tests to detect misfolded proteins for the early diagnosis of neurodegenerative diseases such as Parkinson's and Alzheimer's.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Amprion Comparables
Compare Amprion with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CND Life Sciences | 87% | |
| Sunbird Bio | 81% | |
| C2N Diagnostics | 80% |
Amprion Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 9, 2024 | ||||
| Grant | Sep 12, 2024 | ||||
| Grant | May 10, 2022 | ||||
| Grant | Apr 15, 2021 | ||||
| Grant | Nov 15, 2020 |
Key People
Founding team and executive leadership
Amprion Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Formation Venture Engineering | Series B |
| ALS Network | Grant |
| National Institute of Neurological Disorders and Stroke | Grant |
| Alzheimer's Drug Discovery Foundation | Grant, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 80% MoM, reaching 4.8K.
- Jul 13, 2026
Open roles increased to 10, 2.1x the trailing average.
Recent news
Latest coverage and updates
- launchesSep 18, 2026
Amprion Inc. launched spinal fluid test on Sep 15th '26.
- attends_eventSep 18, 2026
Amprion Inc. will attend event 2026 International Congress of Parkinson's Disease and Movement Disorders on Oct 8th '26.
- launchesSep 15, 2026
Amprion Inc. launches SAAmplify-?SYN Plus.
- partners_withAug 12, 2026
Amprion Inc. partnered with MLM Medical Labs GmbH on Aug 12th '26.
- partners_withJul 29, 2026
Amprion Inc. partners with Mayo Medical Laboratories.
Amprion Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Amprion's valuation, stock price, and market status.
Is Amprion a public or private company?
Amprion is a private company.
What is the current stock price of Amprion?
Amprion is a private company with no public stock price. No recent secondary market data is available.
How much is Amprion worth (valuation)?
Valuation information for Amprion is not publicly available.
Can I buy Amprion stock?
Amprion shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Amprion's last funding round?
Amprion's most recent funding round was Series B on October 9, 2024.
Who are the main investors in Amprion?
Key investors in Amprion include Formation Venture Engineering.
Will Amprion IPO soon?
No public IPO plans have been announced for Amprion.
How can I track Amprion secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Amprion's secondary market activity and sign up for updates.